HomeZTS • NYSE
add
Zoetis Inc
Previous close
$125.64
Day range
$125.65 - $130.65
Year range
$115.25 - $177.00
Market cap
55.81B USD
Avg Volume
4.75M
P/E ratio
21.03
Dividend yield
1.67%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.39B | 3.02% |
Operating expense | 848.00M | 1.07% |
Net income | 603.00M | 3.79% |
Net profit margin | 25.26 | 0.72% |
Earnings per share | 1.48 | 5.71% |
EBITDA | 954.00M | 15.22% |
Effective tax rate | 20.76% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.08B | 4.88% |
Total assets | 15.47B | 8.64% |
Total liabilities | 12.14B | 28.19% |
Total equity | 3.33B | — |
Shares outstanding | 422.13M | — |
Price to book | 16.03 | — |
Return on assets | 13.52% | — |
Return on capital | 16.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 603.00M | 3.79% |
Cash from operations | 893.00M | -1.33% |
Cash from investing | -166.00M | -231.75% |
Cash from financing | -495.00M | 33.56% |
Net change in cash | 228.00M | -16.48% |
Free cash flow | 881.88M | -29.44% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
14,500